Hik. Alibhai et al., CARDIOPULMONARY EFFECTS OF COMBINATIONS OF MEDETOMIDINE HYDROCHLORIDEAND ATROPINE SULFATE IN DOGS, Veterinary record, 138(1), 1996, pp. 11-13
Medetomidine and xylazine are alpha 2 adrenoceptor agonists which are
used as sedatives and premedicants in small animals, However, bradycar
dia is a side effect and the use of atropine sulphate has been recomme
nded to counteract it. This study investigated the effects of combinin
g medetomidine (40 mu g/kg) and atropine (30 mu g/kg) on the cardiopul
monary function of six dogs. Medetomidine administered alone caused se
vere bradycardia, but hypertension was mild and transient, Medetomidin
e and atropine administered together caused an initial bradycardia, bu
t within 15 minutes there was tachycardia accompanied by a mean arteri
al blood pressure of 210 mm Hg. When atropine was administered 30 minu
tes before medetomidine, tachycardia and hypertension were observed wi
thin five minutes of the medetomidine injection, Thus, although atropi
ne will counteract medetomidine-induced bradycardia, its use results i
n prolonged and severe hypertension, in association with the tachycard
ia, Although atropine may be life-saving when bradycardia is profound,
its indiscriminate use in combination with alpha 2 adrenoceptor agoni
sts may be disadvantageous.